The perioperative efficacy and safety of antifibrinolytics in adult spinal fusion surgery

Spine

Volumn 43, Issue 16, 2018, Pages E949-E958

  Lu, Victor M ^a   Ho, Yam Ting ^b   Nambiar, Mithun ^c   Mobbs, Ralph J ^a   Phan, Kevin ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Adult; Antifibrinolytic; Blood loss; Complications; Epsilon aminocaproic acid; Hematology; Meta Analysis; Spinal fusion; Spine surgery; Systematic review; Tranexamic acid.

Indexed keywords

AMINOCAPROIC ACID; D DIMER; FIBRINOGEN; HEMOGLOBIN; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ADULT; CLINICAL OUTCOME; CONTROLLED STUDY; DATA EXTRACTION; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFORMATION RETRIEVAL; MAJOR CLINICAL STUDY; OPERATION DURATION; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PLATELET COUNT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPINE FUSION; SURGICAL PATIENT; SYSTEMATIC REVIEW; META ANALYSIS; PROCEDURES; SPINE DISEASE; TREATMENT OUTCOME; TRENDS;

ADULT; ANTIFIBRINOLYTIC AGENTS; BLOOD LOSS, SURGICAL; HUMANS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SPINAL DISEASES; SPINAL FUSION; TREATMENT OUTCOME;

EID: 85057052626     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0000000000002580     Document Type: Review

References (24)

1. Hu SS. Blood loss in adult spinal surgery. Eur Spine J 2004;13 (suppl 1):S3-5.
2. Szpalski M, Gunzburg R, Sztern B. An overview of blood-sparing techniques used in spine surgery during the perioperative period. Eur Spine J 2004;13 (suppl 1):S18-27.
3. Seicean A, Alan N, Seicean S, et al. The effect of blood transfusion on short-Term, perioperative outcomes in elective spine surgery. J Clin Neurosci 2014;21:1579-85.
4. Neilipovitz DT. Tranexamic acid for major spinal surgery. Eur Spine J 2004;13 (suppl 1):S62-5.
5. Raksakietisak M, Sathitkarnmanee B, Srisaen P, et al. Two doses of tranexamic acid reduce blood transfusion in complex spine surgery: A prospective randomized study. Spine (Phila Pa 1976) 2015; 40:E1257-63.
6. Tsutsumimoto T, Shimogata M, Ohta H, et al. Tranexamic acid reduces perioperative blood loss in cervical laminoplasty: A prospective randomized study. Spine (Phila Pa 1976) 2011;36:1913-8.
7. Fu Y, Shi Z, Han B, et al. Comparing efficacy and safety of 2 methods of tranexamic acid administration in reducing blood loss following total knee arthroplasty: A meta-Analysis. Medicine (Baltimore) 2016;95:e5583.
8. Ishida K, Tsumura N, Kitagawa A, et al. Intra-Articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. IntOrthop 2011;35:1639-45.
9. Myles PS, Smith JA, Forbes A, et al. Tranexamic acid in patients undergoing coronary-Artery surgery. N Engl J Med 2017;376: 136-48.
10. Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011;Cd001886.
11. Shi H, Ou Y, Jiang D, et al. Tranexamic acid reduces perioperative blood loss of posterior lumbar surgery for stenosis or spondylolisthesis: A randomized trial. Medicine 2017;96:e5718.
12. Ratnoff OD. Epsilon aminocaproic acid-A dangerous weapon. N Engl J Med 1969;280:1124-5.
13. Hardy JF, Belisle S. Natural and synthetic antifibrinolytics in adult cardiac surgery: efficacy, effectiveness and efficiency. Can J Anaesth 1994;41:1104-12.
14. Eubanks JD. Antifibrinolytics in major orthopaedic surgery. J Am Acad Orthop Surg 2010;18:132-8.
15. Andreasen JJ. Pharmacologic methods to reduce postoperative bleeding in adult cardiac surgery. A mini-review. Curr Pharm Des 2013;19:3992-5.
16. Nicolau-Raducu R, Ku TC, Ganier DR, et al. Epsilonaminocaproic acid has no association with thromboembolic complications, renal failure, or mortality after liver transplantation. J Cardiothorac Vasc Anesth 2016;30:917-23.
17. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-Analyses: The PRISMA statement. PLoS Med 2009;6:e1000097.
18. Phan K, Mobbs RJ. Systematic reviews and meta-Analyses in spine surgery, neurosurgery and orthopedics: guidelines for the surgeon scientist. J Spine Surg 2015;1:19-27.
19. Stroup DF, Berlin JA, Morton SC, et al. Meta-Analysis of observational studies in epidemiology: A proposal for reporting. Meta-Analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12.
20. Tengborn L, Blomback M, Berntorp E. Tranexamic acid-An old drug still going strong and making a revival. Thromb Res 2015;135:231-42.
21. Tuttle JR, Ritterman SA, Cassidy DB, et al. Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. J Arthroplasty 2014;29:1512-5.
22. Rohde JM, Dimcheff DE, Blumberg N, et al. Health care-Associated infection after red blood cell transfusion: A systematic review and meta-Analysis. JAMA 2014;311:1317-26.
23. Peters A, Verma K, Slobodyanyuk K, et al. Antifibrinolytics reduce blood loss in adult spinal deformity surgery: A prospective, randomized controlled trial. Spine (Phila Pa 1976) 2015;40:E443-9.
24. Basques BA, Anandasivam NS, Webb ML, et al. Risk factors for blood transfusion with primary posterior lumbar fusion. Spine (Phila Pa 1976) 2015;40:1792-7.